Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink

Abstract Background To address a current paucity of European data, this study developed equations to predict risks of mortality, major adverse cardiac events (MACE) and renin angiotensin-aldosterone system inhibitor (RAASi) discontinuation using time-varying serum potassium and other covariates, in...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:BMC Nephrology
المؤلفون الرئيسيون: Hans Furuland, Phil McEwan, Marc Evans, Cecilia Linde, Daniel Ayoubkhani, Ameet Bakhai, Eirini Palaka, Hayley Bennett, Lei Qin
التنسيق: مقال
اللغة:الإنجليزية
منشور في: BMC 2018-08-01
الموضوعات:
Hyperkalaemia
Serum potassium; chronic kidney disease
Mortality
Major adverse cardiac event
RAASi discontinuation
الوصول للمادة أونلاين:http://link.springer.com/article/10.1186/s12882-018-1007-1

الانترنت

http://link.springer.com/article/10.1186/s12882-018-1007-1

مواد مشابهة